CorMedix Inc. — Director's Dealing 2012

Jan 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2012-01-06

Reporting Person: Lefkowitz Steven W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-06	Stock Option (Right to Buy)	$0.29	A	30000	Acquired	2022-01-06	Common Stock, $0.001 par value per share (30000)	Direct

Footnotes

F1: The options vest in full on the first anniversary of the date of grant.